Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)GlobeNewsWire • 07/14/22
Codexis Announces Preliminary Second Quarter 2022 Results and Updates GuidanceGlobeNewsWire • 07/14/22
Codexis (CDXS) Surges 9.7%: Is This an Indication of Further Gains?Zacks Investment Research • 06/27/22
Codexis Announces the Publication of Research Demonstrating Proof of Concept for Chemoenzymatic Site-Selective Bioconjugation of Native PeptidesGlobeNewsWire • 06/17/22
Codexis, Inc. (CDXS) CEO John Nicols on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/05/22
Codexis to Present Data Highlighting Three Gene Therapy Programs at the ASGCT 25th Annual MeetingGlobeNewsWire • 05/02/22
After Plunging 39.6% in 4 Weeks, Here's Why the Trend Might Reverse for Codexis (CDXS)Zacks Investment Research • 04/27/22
Codexis, Inc. (CDXS) CEO John Nicols on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/25/22
Codexis to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24GlobeNewsWire • 02/10/22
Codexis (CDXS) Surges 6.2%: Is This an Indication of Further Gains?Zacks Investment Research • 02/10/22
Week 52 MDA Breakout Stocks - December 2021: Short-Term Picks To Give You An EdgeSeeking Alpha • 12/24/21